Still, the FDA stood its ground, giving 503A facilities until February 18 to stop production, and 503Bs until March 19but it wasnt going to enforce any of this while the lawsuit was pending
Main Research Findings 1) Administration of Melanotan II to adult male mice was found to effectively improve autism-like behavioral deficits
Lau J, Bloch P, Schaffer L, Pettersson I, Spetzler J, Kofoed J, et al
Hasan AA, Kalinina E, Tatarskiy V, Shtil A
April Jorge from Massachusetts General Hospital in Boston underscored the critical need for new therapies to tackle lupus-related complications
In addition to blood transfusions and iron chelation, hormone replacement may be employed